ResearcherXuzhou Medical CollegeActive in the last 2 years
Buwei Teng
Matched on OpenAlex author ID A5111820423. Sources: OpenAlex.
Their work
- Papers
- 7
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2020: 2 papers · 2021: 3 papers · 2022: 1 paper · 2023: none · 2024: 1 paper
Papers 7
- Personalized three-year survival prediction and prognosis forecast by interpretable machine learning for pancreatic cancer patients: a population-based study a… Co-author DOI 10.3389/fonc.2024.1488118↗
- Correction to "Genome-wide CRISPR-Cas9 screening identifies that hypoxia-inducible factor-1a-induced CBX8 transcription promotes pancreatic cancer progression … Co-author DOI 10.4251/wjgo.v14.i10.2085↗
- M2 Macrophage-Derived Exosomes Promote Angiogenesis and Growth of Pancreatic Ductal Adenocarcinoma by Targeting E2F2. Co-author DOI 10.1016/j.ymthe.2020.11.024↗
- Abnormal expression of lncRNA UCA1 disturbed cell apoptosis through mediating mitochondrial dynamics in PDAC. Co-author DOI 10.4149/neo_2020_200629n671↗
- Genome-wide CRISPR-Cas9 screening identifies that hypoxia-inducible factor-1a-induced CBX8 transcription promotes pancreatic cancer progression via IRS1/AKT ax… Co-author DOI 10.4251/wjgo.v13.i11.1709↗
- Hypoxic Tumor-Derived Exosomal Long Noncoding RNA UCA1 Promotes Angiogenesis via miR-96-5p/AMOTL2 in Pancreatic Cancer. Co-author DOI 10.1016/j.omtn.2020.08.021↗
- Tumor-Infiltrating Leukocyte Compositions and Prognostic Immune-Related Genes in Pancreatic Cancer. Co-author DOI 10.21203/rs.3.rs-119677/v1↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Zengya Guo · 5 shared papers, 2020–2022 · strength 0.70
- Paper Correction to "Genome-wide CRISPR-Cas9 screening identifies that hypoxia-inducible factor-1a-induced CBX8 transcription… DOI 10.4251/wjgo.v14.i10.2085↗
- Paper Genome-wide CRISPR-Cas9 screening identifies that hypoxia-inducible factor-1a-induced CBX8 transcription promotes pancr… DOI 10.4251/wjgo.v13.i11.1709↗
- Paper Tumor-Infiltrating Leukocyte Compositions and Prognostic Immune-Related Genes in Pancreatic Cancer. DOI 10.21203/rs.3.rs-119677/v1↗
- Yuhan Yang · 5 shared papers, 2020–2022 · strength 0.70
- Paper Correction to "Genome-wide CRISPR-Cas9 screening identifies that hypoxia-inducible factor-1a-induced CBX8 transcription… DOI 10.4251/wjgo.v14.i10.2085↗
- Paper Genome-wide CRISPR-Cas9 screening identifies that hypoxia-inducible factor-1a-induced CBX8 transcription promotes pancr… DOI 10.4251/wjgo.v13.i11.1709↗
- Paper Tumor-Infiltrating Leukocyte Compositions and Prognostic Immune-Related Genes in Pancreatic Cancer. DOI 10.21203/rs.3.rs-119677/v1↗
- Zhengjun Qiu · 5 shared papers, 2020–2022 · strength 0.70
- Paper Correction to "Genome-wide CRISPR-Cas9 screening identifies that hypoxia-inducible factor-1a-induced CBX8 transcription… DOI 10.4251/wjgo.v14.i10.2085↗
- Paper Genome-wide CRISPR-Cas9 screening identifies that hypoxia-inducible factor-1a-induced CBX8 transcription promotes pancr… DOI 10.4251/wjgo.v13.i11.1709↗
- Paper Tumor-Infiltrating Leukocyte Compositions and Prognostic Immune-Related Genes in Pancreatic Cancer. DOI 10.21203/rs.3.rs-119677/v1↗
- Kun-Dong Zhang · 2 shared papers, 2021–2022 · strength 0.34
- Paper Correction to "Genome-wide CRISPR-Cas9 screening identifies that hypoxia-inducible factor-1a-induced CBX8 transcription… DOI 10.4251/wjgo.v14.i10.2085↗
- Paper Genome-wide CRISPR-Cas9 screening identifies that hypoxia-inducible factor-1a-induced CBX8 transcription promotes pancr… DOI 10.4251/wjgo.v13.i11.1709↗
- Jun Ma · 1 shared paper, 2024 · strength 0.26
- Xiaofeng Zhang · 1 shared paper, 2024 · strength 0.26
- Xiaofeng Wang · 2 shared papers, 2020–2021 · strength 0.24
- Chen Huang · 2 shared papers, 2020–2021 · strength 0.23
- Paper M2 Macrophage-Derived Exosomes Promote Angiogenesis and Growth of Pancreatic Ductal Adenocarcinoma by Targeting E2F2. DOI 10.1016/j.ymthe.2020.11.024↗
- Paper Hypoxic Tumor-Derived Exosomal Long Noncoding RNA UCA1 Promotes Angiogenesis via miR-96-5p/AMOTL2 in Pancreatic Cancer. DOI 10.1016/j.omtn.2020.08.021↗
- Wei Li · 1 shared paper, 2021 · strength 0.19
- Zhong Wang · 1 shared paper, 2021 · strength 0.19
- Peng Cao · 1 shared paper, 2021 · strength 0.12
- Weiwei Chen · 1 shared paper, 2020 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.